Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.155 USD | +6.94% | -1.69% | +110.91% |
05-14 | Xilio Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-19 | Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+110.91% | 39.86M | |
+33.01% | 50.85B | |
+0.05% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+11.18% | 26.11B | |
-21.74% | 19.13B | |
+8.55% | 13.05B | |
+27.91% | 12.16B | |
+24.30% | 12.08B |
- Stock Market
- Equities
- XLO Stock
- News Xilio Therapeutics, Inc.
- Cowen Starts Xilio Therapeutics at Outperform